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After minus-strand strong-stop DNA (2sssDNA) is synthesized, the RNA template is degraded by the RNase H activity of
the reverse transcriptase (RT), generating a single-stranded DNA. The 39 end of 2sssDNA from HIV-1 can form a hairpin; this
hairpin will self-prime in vitro. We previously used a model substrate, 2R ssDNA, which corresponds to the 39 end of the
2sssDNA of HIV-1, to show that the self-priming of this model substrate could be prevented by annealing a 17-nt-long DNA
oligonucleotide to the 39 end of 2R ssDNA in the presence of HIV-1 nucleocapsid (NC) protein. Similar model substrates were
prepared for HIV-2 and HTLV-1; the R regions of these two viruses are longer and form more complex structures than the
R region of the HIV-1 genome. However, the size of the R region and the complexity of the secondary structures they can
form do not affect self-priming or its prevention. The efficiency of the self-priming is related to the relative stabilities of the
conformations of 2R ssDNA that can and cannot induce self-priming. For the three viruses (HIV-1, HIV-2, and HTLV-1), the
size of the DNA oligonucleotide needed to block self-priming in the presence of NC is similar to the expected size of the piece
of RNA left after degradation of the RNA template during reverse transcription. We also found that when the 39 end of 2R
ssDNA is annealed to a complementary DNA oligonucleotide, it is a good substrate for efficient nonspecific strand transfer
to other single-stranded DNA molecules.
Key Words: self-priming; reverse transcriptase; nucleocapsid protein.
m
2
i
p
s
o
f
v
(INTRODUCTION
Retroviral reverse transcriptases (RTs) synthesize mi-
nus-strand strong-stop DNA (2sssDNA) using the RNA
genome as a template. DNA synthesis is initiated from a
primer tRNA bound to the primer-binding site (PBS) (Cof-
fin et al., 1997; Goff, 1990; Whitcomb and Hughes, 1992).
To synthesize 2sssDNA, RT copies the U5 and R regions
at the 59 end of the genome. The synthesis of 2sssDNA
creates an RNA/DNA heteroduplex; the RNase H activity
of RT degrades the RNA in this heteroduplex (Hughes et
al., 1996; Palaniappan et al., 1996; Schatz et al., 1990).
The nascent single-stranded DNA is then transferred to
the R region at the 39 end of the RNA genome and
minus-strand DNA synthesis continues (Coffin, 1979;
Kulpa et al., 1997; Panganiban and Fiore, 1988).
The R region of human immunodeficiency virus type 1
(HIV-1) genomic RNA [GenBank Accession No. GI
328415, positions 455 to 550 (Adachi et al., 1986)] con-
tains two large hairpins, the poly(A) and TAR-1 hairpins
(Berkhout et al., 1989; Muesing et al., 1987). In vitro,
nascent HIV-1 2sssDNA can form secondary structures
that induce self-priming (Driscoll and Hughes, 2000;
Driscoll et al., 2001; Guo et al., 1997). If self-priming
occurs, strand transfer is prevented (Guo et al., 1997).
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278HIV-1 nucleocapsid (NC), a 55-amino-acid-long protein
that contains two zinc fingers, is synthesized as part of
the Gag polyprotein. HIV-1 NC can prevent self-priming
of 2sssDNA in vitro (Driscoll and Hughes, 2000; Guo et
al., 1997) and also promotes strand transfer (Lapadat-
Tapolsky et al., 1995; Li et al., 1996; Rein et al., 1998).
Recently, it was shown that HIV-1 NC and a 17-base-long
DNA oligonucleotide complementary to the 39 end of a
odel substrate that corresponds to the 39 end of the
sssDNA of HIV-1 are sufficient to prevent self-priming
n an in vitro reaction (Driscoll and Hughes, 2000).
The R regions of human immunodeficiency virus type
2 (HIV-2) [GenBank Accession No. GI 1332361, positions
1 to 173 (Clavel et al., 1986)] and human T-cell leukemia
virus type 1 (HTLV-1) [GenBank Accession No. GI 221866,
positions 354 to 581 (Malik et al., 1988)] are much longer
than the R region of HIV-1 (173, 228, and 96 nucleotides,
respectively). In the case of HIV-2, it was proposed that
this region of the genomic RNA contains three loops that
form the transactivation response element (TAR-2)
(Emerman et al., 1987; Fenrick et al., 1989). This structure
rediction was confirmed by RNase susceptibility mea-
urements (Berkhout, 1992). Similar studies performed
n the genome of HTLV-1 demonstrated that this region
orms a complex secondary structure at the 59 end of the
iral RNA, the cis-acting Rex-responsive element (RxRE)
Askjaer and Kjems, 1998; Toyoshima et al., 1990).
The secondary structures in 2sssDNAs from these
wo retroviruses might form, at their 39 ends, secondary
tructures that induce self-priming. We prepared single-
2792sssDNA SELF-PRIMINGstranded DNA model substrates (2R ssDNAs) for HIV-2
and HTLV-1 that are complementary to the R region of
the RNA genome. We found that both of these 2R
ssDNAs can self-prime and the efficiency of the self-
priming is dependent on the relative stabilities of the
structures that can, and cannot, induce self-priming, not
on the size and the complexity of R structures.
After 2sssDNA is synthesized, RT degrades the RNA
template leaving a 14- to 18-nt-long RNA oligonucleotide
annealed to the 39 end of the nascent DNA strand
(Driscoll et al., 2001; Fu and Taylor, 1992). In the three
cases that we have studied, a DNA oligonucleotide of a
similar size is able to prevent self-priming of 2R ssDNA
in the presence of HIV-1 NC; longer oligonucleotides can
be required in the absence of NC. Thus, the secondary
structures at the 39 end of the 2sssDNA that are related
to the RNA structures necessary for interactions with
regulatory proteins are sufficiently unstable that the
piece of RNA left at the 39 end of 2sssDNA is able to
prevent self-priming in the presence of NC. The preven-
tion of self-priming does not depend on the stability of
the overall structure but only on the stability of the struc-
tural element at the 39 end of 2R ssDNA. However, if a
DNA oligonucleotide sufficient to block self-priming is
annealed to the 39 end of 2R ssDNA, there can be
efficient nonspecific strand transfer to single-stranded
DNA molecules, even if the single-stranded DNAs are
present in the reaction in relatively low concentration.
RESULTS
2R ssDNA secondary structure predictions
A single-stranded DNA (ssDNA) molecule can have
different conformations in solution. At equilibrium, the
conformation with the lowest free energy (DG) will be
preferred (the largest portion of the population) and the
relative proportion of each of the various possible con-
formations in the population will be related to the differ-
ence in the free energy between the conformations.
Because the R region of the RNA genomes of HIV-1
(Berkhout et al., 1989; Muesing et al., 1987), HIV-2 (Berk-
hout, 1992), and HTLV-1 (Askjaer and Kjems, 1998) con-
tain secondary structure elements (Fig. 1A), the minus-
strand DNAs copied from these regions (2R ssDNA)
might also form stable secondary structures. However,
the thermodynamic parameters governing RNA folding
are different from those governing DNA folding, and
these differences may affect the conformation and the
free energy of the most stable structures. Because the
ability of a ssDNA to self-prime is directly linked to its
own folding and not to the folding of the complementary
RNA molecule, we predicted the possible secondary
structures of the 2R ssDNAs and their free energies (Fig.
1, Table 1) using mfold version 3.0 software (Materials
and Methods). Each possible conformation was catego-
rized according to its ability to self-prime (was the 39 enddouble-stranded with another part of the molecule or
not?). In the case of HIV-1 2R ssDNA, we found that the
most stable structure has a DG of 29.8 kcal/mol, but this
structure cannot self-prime (the 39 end is not double-
stranded). In the most stable structure that is able to
self-prime (the 39 end is double-stranded) the DG is 28.4
kcal/mol. The secondary structure element of the 39 end
that can induce self-priming is the one shown in Fig. 1B.
The most stable DNA structure in which the folding of the
39 end is similar to the folding of the 59 end of the RNA
(the 11 bases at the 39 end doubled-stranded with bases
at positions 114 to 123) has a higher free energy (DG of
27.4 kcal/mol). When mutations were introduced in the
HIV-1 R sequence to remove three of the mismatches
(only the 3-base bulge and a 1-base bubble were re-
tained) as described by Driscoll and Hughes (2000), the
hairpin structure in the RNA is much more stable (DG of
250.6 kcal/mol). Moreover the hairpin is also the most
stable structure in a 2R ssDNA containing similar mu-
tations (DG of 225.5 kcal/mol). In the case of HIV-2, the
most stable structure of the 2R ssDNA (DG of 224.9
kcal/mol) is not able to self-prime. The most stable struc-
ture able to induce self-priming (DG of 221.6 kcal/mol)
has the 39 end structure shown in Fig. 1B. The structure
in which the folding of the 39 end of the DNA is similar to
the folding of the 59 end of the RNA is less stable (DG of
214.6 kcal/mol). However, the 39 end of the HIV-2 2R
ssDNA, which is the portion of the overall structure
involved in the self-priming, is less stable (has more
mismatches) than the structures that can induce self-
priming of HIV-1 2R ssDNA. For HTLV-1, the most stable
DNA structure is able to induce self-priming and the 39
end of the DNA has a structure similar to the 59 end of
the RNA (stem loop between bases 1 to 25 in the RNA
structure) (DG of 226.7 kcal/mol). However, in the case
of HTLV-1, the structural element involving the very 39
end of 2R ssDNA is relatively small and has several
mismatches (Fig. 1B).
According to the structure predictions, we would ex-
pect that all these 2R ssDNAs could induce self-priming
but that HIV-2 2R ssDNA would self-prime less effi-
ciently than either the HIV-1 or the HTLV-1 2R ssDNAs.
Moreover, the structural element at the 39 end of the
HIV-1 2R ssDNA that induces self-priming seems to be
more stable (size and quality of the basepairing) than the
corresponding structures inducing the self-priming of the
HIV-2 and HTLV-1 2R ssDNAs.
Nascent HIV-2 and HTLV-1 2R ssDNAs can
self-prime
To look at the ability of nascent HIV-2 and HTLV-1 2R
ssDNAs to self-prime, R RNAs were synthesized, purified
as described (Materials and Methods), and annealed to
a 59 end-labeled DNA oligonucleotide complementary to
the 39 end of the RNA. Then, the complementary DNA
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2812sssDNA SELF-PRIMINGstrand (2R ssDNA) was synthesized by HIV-1 RT. Reac-
tion products were analyzed on a denaturing acrylamide
gel (Fig. 2A).
In both cases, full-size DNA was synthesized: 173 nt
long for HIV-2 (lane 1) and 228 nt long for HTLV-1 (lane 3).
Shorter products were also synthesized (data not
shown). These products arise from RT pausing at sec-
ondary structures of the RNA template (Driscoll et al.,
2001). Longer products could also be detected showing
that both full-length DNAs can self-prime. In the case of
HIV-2, self-primed products typically represented 20 to
30% of the total full-sized DNAs (full-sized or longer); in
the case of HTLV-1, more than 60% of the full-length
products self-primed. As seen previously with HIV-1 2R
ssDNA (Driscoll and Hughes, 2000), the longest self-
primed product was shorter than what would be ex-
pected if the entire 2R ssDNA was copied. We believe
that the high level of secondary structure in each of the
2R ssDNAs prevented the synthesis of a full-length
self-primed product.
Similar experiments were performed in presence of a
twofold excess of HIV-1 NC, assuming that each NC
molecule covers 7 nucleotides (You et al., 1993). The
amount of nucleic acid used in the calculations corre-
sponds to the amount of RNA and primer present at the
beginning of the reaction. In fact, the actual NC coating
levels varied during the course of the reaction due to
polymerization of the DNA strand and degradation of the
FIG. 1. Secondary structures of HIV-1, HIV-2, and HTLV-1 R RNAs and
R RNA as proposed by Berkhout et al. (1989). (2) The structure of HIV-2
RNA as proposed by Askjaer and Kjems (1998). The 59 end is indicated
T
The DG of the Possible Conformations of R RN
DNA
R size
(nt)
Most stable R RNA
structurea
M
2DGd Structure (Fig. 1) 2
HIV-1 96 38.2 A1
Modified HIV-1 98 46.5 A1 2
HIV-2 173 67.3 A2 2
HTLV-1 228 63.4 A3 2
a Calculations were performed at 37°C with [NaCl] 5 1 M, [MgCl2]
b Calculations were performed at 37°C with [NaCl] 5 80 mM, [M
Materials and Methods).
c Structure with the 39 end of 2R ssDNA forming a secondary struct
d In kcal/mol.
e If the last base at the 39 end of 2R ssDNA is base-paired, then 2R
R ssDNA has no ability to self-prime in this conformation (N).
f Structure showing only the 39 end of 2R ssDNA.
g DG for a folding of 2R ssDNA similar to the folding of R RNA presssDNA that could induce self-priming. Calculations were performed using mf
NaCl and 6 mM MgCl2. Structures of (1) HIV-1, (2) HIV-2, (3) HTLV-1. The 39 eRNA template. Under these conditions, HIV-1 NC added
in twofold excess was able to reduce significantly self-
priming of both HIV-2 and HTLV-1 nascent 2R ssDNAs
(Fig. 2A, lanes 2 and 4). These results clearly show that,
in both cases, at least part of the nascent DNA is folded
in a manner that can induce self-priming as predicted by
thermodynamic studies of 2R ssDNA conformations and
that, in vitro, self-priming of the nascent 2R ssDNA can
be prevented by the addition of HIV-1 NC, as previously
shown with HIV-1 R DNA (Driscoll and Hughes, 2000).
Self-priming of HIV-1, HIV-2, and HTLV-1 2R ssDNAs
It was previously shown (Driscoll and Hughes, 2000)
that HIV-1 2R ssDNA can self-prime if incubated with
HIV-1 RT. Similar studies were done with HIV-2 and
HTLV-1 2R ssDNAs. The 2R ssDNAs of HTLV-1 and
HIV-2 are too long (228 and 173 nt, respectively) to be
synthesized chemically. They were prepared from the
corresponding R RNA using SuperScript II RNase H2
reverse transcriptase (Materials and Methods), which is
a mutant form of Moloney murine leukemia virus RT
(Gerard et al., 1997). Gel purified 2R ssDNAs were used
in experiments similar to those done previously with
HIV-1 2R ssDNA (Driscoll and Hughes, 2000). The ex-
periments were done using the same conditions for
HIV-1, HIV-2, and HTLV-1 2R ssDNAs (100 fmol of DNA in
13 RT binding buffer in the presence of 200 fmol of HIV-1
sDNAs. (A) Secondary structures of R RNAs. (1) The structure of HIV-1
as proposed by Emerman et al. (1987). (3) The structure of HTLV-1 R
arrow. (B) Possible secondary structure elements at the 39 end of 2R
d 2R ssDNAs from HIV-1, HIV-2, and HTLV-1
ble 2R ssDNA
ructureb
DNA folding inducing
self-priming
DNA folding
(;RNA)c
Self-priminge 2DGd Structure (Fig. 1) f 2DGd,g
N 8.4 B1 7.4
Y 21.4 B1 25.5
N 21.6 B2 14.6
Y 26.7 B3 26.7
using Zuker algorithm (Materials and Methods).
6 mM with oligonucleotide correction using SantaLucia algorithm
ment similar to what was observed with the 59 end of R RNA (Fig. 1A).
A has the ability to self-prime (Y). If this base is single-stranded, then
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282 GOLINELLI AND HUGHESRT at 37°C for 1 h) (Fig. 2B). As expected, all three 2R
ssDNAs could undergo self-priming and self-primed
products were similar to what was seen with the nascent
DNAs [Fig. 2A; (Driscoll and Hughes, 2000)]. However,
the relative amounts of the different DNA products were,
in some cases, modestly different (especially for HTLV-
1). As seen with the nascent DNAs, more self-priming
occurred with HIV-1 and HTLV-1 2R ssDNAs than with
HIV-2 2R ssDNA (50 to 70%, 70 to 80%, and 20 to 30%,
respectively, under these conditions).
DNA digestion and analysis on a sequencing gel
showed that, in the case of HIV-2 2R ssDNA, the major
self-primed product is about 223 nt long (50-base addi-
tion). The size of the extension produced by the self-
priming reaction corresponds in size to the stem loop
between nucleotides 124 and 173 in the RNA structure
(Fig. 1A). In the case of HTLV-1, the shortest product is
239 nt long (11-base addition) and there is a second
product about 280 to 285 nt long (about a 52- to 57-base
addition). In both cases the sizes and the sequences of
the major self-primed products are consistent with sec-
ondary structures similar to the structures shown in
Fig. 1A.
Self-priming can be blocked by a DNA oligonucleotide
and HIV-1 NC
When 2R ssDNA was made from RNA by HIV-1 RT,
HIV-1 NC could prevent self-priming. But when chemi-
cally synthesized HIV-1 2R ssDNA was used, HIV-1 NC
was able to prevent self-priming only in the presence of
a 17-nt-long DNA oligonucleotide complementary to the
FIG. 2. Self-priming of HIV-1, HIV-2, and HTLV-1 2R ssDNAs. (A) Ana
ffects of HIV-1 NC addition. R RNA was annealed to a 32P-59-end-labele
by 200 fmol HIV-1 RT for 1 h at 37°C in 13 RT binding buffer and the rea
without NC (lane 1) and with NC added in twofold excess (lane 2). HTLV
4). The full-size DNA (2R ssDNA) is 173 nt long in the case of HIV-2 an
of HIV-1, HIV-2, and HTLV-1 2R ssDNAs; 100 fmol DNA (internally labe
RT binding buffer with 200 fmol HIV-1 RT at 37°C for 1 h. Reaction prod39 end of HIV-1 2R ssDNA (Driscoll and Hughes, 2000).
The short DNA oligonucleotide used in these experi-ments mimics the RNA fragment left after RNase H di-
gestion of the RNA template. In the absence of NC, a
25-nt-long DNA oligonucleotide was able to prevent self-
priming of HIV-1 2R ssDNA (data not shown). When
mutations were introduced in the HIV-1 2R ssDNA se-
quence to improve the base-pairing and, consequently,
the stability of the hairpin, self-priming was favored and
could not be prevented even by the addition of a 21-mer
DNA oligonucleotide and HIV-1 NC (Driscoll and
Hughes, 2000). Similar experiments were done with
HIV-2 and HTLV-1 2R ssDNA (Figs. 3 and 4, Table 2) to
see how the size, sequence, and secondary structures of
2R ssDNA affect what is required to prevent self-prim-
ing.
DNA oligomers complementary to the 39 end of the 2R
sDNAs were synthesized (HIV-1 block, HIV-2 block, and
TLV block oligonucleotides for HIV-1, HIV-2, and HTLV-1
R ssDNAs, respectively) (Fig. 3). DNA oligomers were
dded to the 2R ssDNAs in 70-fold excess. The mixture
was heated to 65°C and cooled to room temperature. If
the DNA oligonucleotide is short, annealing of the 39 end
of 2R ssDNA to another part of 2R ssDNA is thermody-
namically favored relative to the formation of the DNA
oligonucleotide/2R ssDNA duplex and, consequently,
self-priming is not affected. As the size of the DNA
oligonucleotide increases, the free energy of the DNA
oligonucleotide/2R ssDNA duplex decreases and for-
mation of the duplex becomes more thermodynamically
favored; self-priming is reduced or eliminated. The size
of the DNA oligonucleotide needed to abolish self-prim-
ing depends on the free energy (and the stability) of the
f nascent HIV-2 and HTLV-1 2R ssDNAs synthesized by HIV-1 RT and
er complementary to the 39 end of the RNA. The DNA was synthesized
as analyzed on a 5% denaturing polyacrylamide gel. HIV-2 2R ssDNA
ssDNA without NC (lane 3) and with NC added in twofold excess (lane
t long in the case of HTLV-1; spp, self-primed product. (B) Self-priming
HIV-2 and HTLV-1, 32P-59-end labeled for HIV-1) was incubated in 13
ere analyzed on a 5% gel. Lane 1, HIV-1; lane 2, HIV-2; lane 3, HTLV-1.lysis o
d prim
ction w
-1 2R
d 228 nstructural element responsible of the self-priming. Thus,
the more stable the structural element inducing self-
d HIV-
u
(
2832sssDNA SELF-PRIMINGpriming is, the longer the DNA oligonucleotide required
to prevent self-priming will be.
In the case of HIV-2 2R ssDNA (Fig. 4A), HIV-1 NC
FIG. 3. Sequences of the 40 bases at the 39 end of HIV-2, HTLV-1, an
sed in this paper.
FIG. 4. Effect of a complementary DNA oligonucleotide and HIV-1 NC
was incubated with a DNA oligonucleotide (9.5 pmol, 70-fold excess) c
room temperature. In the reactions containing NC, the protein was add
The reaction was started by addition of RT start solution and 200 fmo
products were analyzed on a 5% denaturing acrylamide gel. The lowes
of the DNA oligonucleotide used to block self-priming. (B) Internally lab
(4.8 pmol, 70-fold excess) complementary to its 39 end at 65°C for 3 min
performed in 13 RT binding buffer. Reaction products were analyzed on a 4% d
228 nt). Block size is the size (in nt) of the DNA oligonucleotide used to bloc(added in twofold excess) was able, by itself, to reduce
the intensity of the band corresponding to the major
self-primed product (223-nt-long product) by more than
1 2R ssDNAs and at the 59 end of R RNAs and DNA oligonucleotides
ssDNA self-priming. (A) Internally labeled HIV-2 2R ssDNA (135 fmol)
entary to its 39 end at 65°C for 3 min and the solution was cooled to
ofold excess, and the reaction tube was incubated for 5 min at 37°C.
RT and performed in 13 RT binding buffer at 37°C for 1 h. Reaction
corresponds to HIV-2 2R ssDNA (173 nt). Block size is the size (in nt)
TLV-1 2R ssDNA (67 fmol) was incubated with a DNA oligonucleotide
e solution was cooled to room temperature. Similar experiments wereon 2R
omplem
ed in tw
l HIV-1
t band
eled H
and thenaturing acrylamide gel. The lowest band corresponds to 2R ssDNA
k self-priming.
w
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284 GOLINELLI AND HUGHES90% (lanes 1 and 2). This band (and other bands corre-
sponding to the minor self-primed products observed in
lane 1) disappeared if the reaction was done in the
presence of NC and a 14-mer DNA complementary to the
39 end of HIV-2 2R ssDNA (Fig. 4A, lane 6). If the 14-mer
was added in the absence of NC protein, self-priming
was less efficient but still occurred (Fig. 4A, lane 5). In
the absence of HIV-1 NC, no significant self-priming was
observed when a complementary DNA at least 20 bases
long was added to the reaction (Fig. 4A, lane 9).
In the case of HTLV-1 (Fig. 4B), HIV-1 NC alone re-
duced the amount of self-priming by about 80%. The
shortest product disappeared and the amount of the
longest product was significantly reduced. All of the
other minor products disappeared completely. Again, if a
14-mer oligonucleotide was added in presence of HIV-1
NC, self-priming was prevented (Fig. 4B, lane 6). How-
ever, the same 14-mer could also prevent self-priming in
the absence of NC. Despite the fact that HIV-1, HIV-2, and
HTLV-1 2R ssDNAs are different in size, structure, sta-
bility, and ability to self-prime, the size of the DNA oligo-
nucleotide required to prevent self-priming in presence
of NC was similar.
Figures 4A and B show that, in the presence of some
of the DNA blocking oligonucleotides, new DNAs were
synthesized. Because they were synthesized only when
the blocking oligonucleotides were added, they cannot
be self-primed products. These new DNAs can easily be
seen with HIV-2 2R ssDNA and the HIV-2 block 20 and
block 22 oligonucleotides and with HTLV-1 2R ssDNA
and the HTLV block 14, block 17, and block 25 oligonu-
cleotides. The size of the new products increased with
the size of the added oligonucleotides. For reactions
involving HIV-2 2R ssDNA and the HIV-2 block 20 oligo-
nucleotide, DNA digestion and analysis of the products
on a high-resolution sequencing gel showed that, rela-
tive to HIV-2 2R ssDNA, the size of the novel products
as longer by 20 nucleotides or a multiple of 20 (data not
hown). The intensity of these bands varied depending
n the oligonucleotides used; however, there was no
imple relationship between the intensity and the size of
he DNA blocking oligonucleotide. Sequencing products
rom the reaction involving the HIV-2 block 20 oligonu-
TABLE 2
Size of the Smallest DNA Blocking Oligonucleotide Able to Prevent
Self-Priming of HIV-1, HIV-2, and HTLV-1 2R ssDNAs
2R ssDNA
Oligonucleotide
alone (nt)
Oligonucleotide (nt)
1 HIV-1 NC (23)
Improved HIV-1 .21a .21a
HIV-1 25 17a
HIV-2 20 14
HTLV-1 14 14a From Driscoll and Hughes (2000).cleotide and HIV-2 2R ssDNA showed that the extension
products contain sequences complementary to HIV-2
block 20 (data not shown). This means that, in some
cases, when the 39 end of HIV-2 or of HTLV-1 2R ssDNA
was annealed to a piece of DNA to prevent self-priming,
the 39 end of the 2R ssDNA was able to strand transfer
to the 39 end of a single-stranded DNA present in the
reaction. Similar results were obtained with HIV-2 RT and
HIV-2 2R ssDNA (data not shown).
Salt dependence of the self-priming
To study the salt dependence of the self-priming event,
the reactions were performed in the presence of different
amounts of RT binding buffer (Fig. 5). The self-priming of
HIV-1 and HTLV-1 2R ssDNAs have a similar depen-
dence on salt concentration. In these two cases, the
amount of product was not affected by salt concentra-
tions lower than 80 mM (13 RT binding buffer). At higher
salt concentrations, the amount of self-primed product
was reduced. This suggests that the observed salt ef-
fects are probably RT related (polymerization and strand
displacement activities) and not related to folding and/or
secondary structures of the DNA. HIV-2 2R ssDNA self-
priming showed a different salt dependence. For HIV-2
2R ssDNA, the formation of the self-primed product was
slightly more efficient in the presence of 60 mM KCl
(0.753 RT binding buffer) than in the presence of 46 mM
(0.573) or 80 mM (13) KCl. The efficiency of the self-
priming of HIV-2 2R ssDNA was dramatically reduced at
higher salt concentrations. This was not what was ob-
served with HIV-1 and HTLV-1 2R ssDNAs, which sug-
FIG. 5. Salt effects on self-priming of 2R ssDNA; 300 fmol of 2R
ssDNA (internally labeled for HIV-2 and HTLV-1, 59-end-labeled for
HIV-1) was incubated in the presence of 200 fmol HIV-1 RT and RT start
solution for 1 h at 37°C in the presence of different amounts of RT
binding buffer. Reactions were analyzed on a 5% (HIV-1, HIV-2) or 4%
(HTLV-1) denaturing acrylamide gel. For each reaction, the amount of
product and the total amount of DNA were quantitated using Image-
Quant software. The amount of product was expressed as a percent-
age of total DNA present in the reaction. For each DNA template, the
results were then normalized to the results obtained with the lowest
salt concentration (0.53 RT binding buffer).gests a different mechanism; it is likely that some of the
effects of salt are due to changes in the distribution
cE
o
t
t
n
n
m
o
i
r
2
t
2
m
t
s
a
a
f
s
c
F
h
t
a
s
o
r
b
i
o
t
t
H
a
p
w
s
d
T
a
l
H
a
H
f
s
n
s
2852sssDNA SELF-PRIMINGamong the conformations of the HIV-2 2R ssDNA that
an and cannot self-prime.
ffects of the concentration of the HIV-2 block 20
ligonucleotide on the efficiency of the strand
ransfer of HIV-2 2R ssDNA
In the previous experiments, a large excess (70-fold) of
he DNA blocking oligonucleotide was used in the an-
ealing reaction. Consequently, a large amount of oligo-
ucleotide was free in solution after annealing. To deter-
ine whether the free oligonucleotide (HIV-2 block 20
ligonucleotide) affected the strand transfer, the anneal-
ng reaction was fractionated on a G-50 spin column to
emove the free oligonucleotides, and then the purified
R ssDNA annealed to the HIV-2 block 20 oligonucleo-
ide was used in a self-priming experiment (Fig. 6A, lane
). A small amount of the band corresponding to the
ajor self-primed product was present, showing that
here was a small amount of 2R ssDNA that was able to
elf-prime. Either a small amount of 2R ssDNA never
nnealed to the HIV-2 block 20 oligonucleotide or a small
mount of the HIV-2 block 20 oligonucleotide dissociated
rom the 2R ssDNA during or after the purification. The
trand transfer product for the HIV-2 block 20 oligonu-
leotide was present in the control (no G-50 purification,
ig. 6A, lane 9) but was not produced in the reaction that
as no free oligonucleotide. These results indicate that
he strand transfer to HIV-2 block 20 oligonucleotide is
n intermolecular process.
After fractionation of the annealing reaction on a G-50
pin column, variable amounts of the HIV-2 block 20
ligonucleotide were added to a series of polymerization
eactions (Fig. 6A, lanes 3 to 8). The intensity of the
ands corresponding to the strand transfer products
ncreased as the concentration of the free HIV-2 block 20
ligonucleotide increased. These results showed that
here was a direct dependence of the amount of strand
ransfer product on the amount of free oligonucleotide.
owever, strand transfer occurred even if a relatively low
mount of free HIV-2 block 20 oligonucleotide was
resent in the reaction (onefold excess, Fig. 6A, lane 3).
We found that the strand transfer reaction can occur
ith either HIV-2 or HTLV-1 2R ssDNA. In both cases,
trand transfer can use different oligonucleotides with
ifferent 39 end sequences as acceptors (Figs. 3 and 4).
o see if homology between the DNA primer (2R ssDNA)
nd the DNA template (free DNA oligonucleotide in so-
ution) is required, an experiment (Fig. 6B) was done with
IV-2 2R ssDNA and the HTLV block 17 oligonucleotide,
n oligonucleotide complementary to the 39 end of the
TLV-1 2R ssDNA (Fig. 3). If the experiment was per-
ormed in the presence of HTLV block 17 oligonucleotide,
elf-priming occurred because the HTLV block 17 oligo-
ucleotide could not anneal to the 39 end of HIV-2 2R
sDNA (Fig. 6B, lane 1). HIV-2 block 20 oligonucleotideFIG. 6. If the 39 end of 2R ssDNA was annealed to a complementary
DNA oligonucleotide, there could be nonspecific strand transfer. (A)
Effect of the amount of HIV-2 block 20 oligonucleotide on strand
transfer. Lane 1, 200 fmol of internally labeled HIV-2 2R ssDNA was
incubated in 0.73 RT binding buffer for 1 h at 37°C in the presence of
RT start solution and 200 fmol HIV-1 RT. Lanes 2–8, 200 fmol of
internally labeled HIV-2 2R ssDNA was annealed to HIV-2 block 20
oligonucleotide added in 70-fold excess, and then free oligonucleotide
was removed by fractionation of the mixture on a G-50 spin column
equilibrated with 13 RT binding buffer. Various amounts of HIV-2 block
20 oligonucleotide were added and the reactions were performed in
0.73 RT binding buffer for 1 h at 37°C in the presence of RT start
solution and 200 fmol of HIV-1 RT. The reactions were analyzed on a 5%
denaturing polyacrylamide gel. Lane 2, no HIV-2 block 20 oligonucle-
otide was added. Lane 3, the HIV-2 block 20 oligonucleotide was added
in onefold excess (by comparison to the number of template mole-
cules). Lane 4, in threefold excess. Lane 5, in 5-fold excess. Lane 6, in
25-fold excess. Lane 7, in 50-fold excess. Lane 8, in 75-fold excess.
Lane 9, similar experiment but without G-50 purification after the
annealing reaction. The lowest band corresponds to HIV-2 2R ssDNA
(173 nt). (B) HIV-2 2R ssDNA strand transfer to the HTLV block 17
oligonucleotide. Lane 1, 200 fmol of internally labeled HIV-2 2R ssDNA
was annealed to the HTLV block 17 oligonucleotide (added in 70-fold
excess) and then incubated in the presence of 200 fmol of HIV-1 RT for
1 h in 0.73 RT binding buffer at 37°C. Lane 2, 200 fmol on internally
labeled HIV-2 2R ssDNA was annealed to HIV-2 block 20 oligonucle-
otide (added in 70-fold excess) and then the mixture was fractionated
on a G-50 spin column. The HTLV block 17 oligonucleotide was added
in 70-fold excess and the reaction was performed for 1 h at 37°C in the
presence of RT start solution and 200 fmol of HIV-1 RT in 0.73 RT
binding buffer. Lane 3, 200 fmol of HIV-2 2R ssDNA was annealed to
HIV-2 block 20 oligonucleotide (added in 70-fold excess) and the
reaction was performed for 1 h at 37°C in the presence of RT start
solution and 200 fmol of HIV-1 RT.
286 GOLINELLI AND HUGHESwas annealed to HIV-2 2R ssDNA, the annealing reac-
tion was fractionated on a G-50 spin column, and the
HTLV block 17 oligonucleotide was added in a 70-fold
excess (Fig. 6B, lane 2). As expected, the HIV-2 block 20
oligonucleotide prevented the self-priming and strand
transfer products were produced. The products of this
reaction were compared to the products obtained when
the strand transfer was done in presence of the HIV-2
block 20 oligonucleotide (Fig. 6B, lane 3). It can be seen
in the reaction containing HTLV block 17 oligonucleotide
that the strand transfer product was smaller than the
products of the reaction containing HIV-2 block 20 oligo-
nucleotide. Thus, HTLV block 17 oligonucleotide was the
DNA acceptor. These experiments clearly showed that
strand transfer requires that the 39 end of the strand
transfer donor DNA must be annealed to a complemen-
tary piece of DNA and that the strand transfer can occur
even with a strand transfer acceptor which has no sig-
nificant homology with the DNA donor.
DISCUSSION
When the HIV-1 genome is copied in vitro, the nascent
2sssDNA is able to self-prime (Driscoll and Hughes,
2000; Guo et al., 1997; Lapadat-Tapolsky et al., 1997). If
self-priming occurs in vivo, full-length genomic DNA can-
not be synthesized. The R regions of HIV-1, HIV-2, and
HTLV-1 RNAs contain secondary structures (TAR-1,
TAR-2, and RxRE, respectively) (Askjaer and Kjems, 1998;
Berkhout, 1992; Muesing et al., 1987). To see if the cor-
responding 2R ssDNAs can fold into structures that can
self-prime, secondary structure predictions were per-
formed. The minus-strand DNAs from the R regions of
HIV-1, HIV-2, and HTLV-1 have several possible confor-
mations. In the case of HTLV-1, the most stable of the
predicted structures can self-prime; in the cases of HIV-1
and HIV-2 2R ssDNAs, secondary structures that should
be able to self-prime are not the most energetically
favored. As might be expected from these data, HTLV-1
2R ssDNA self-primes more efficiently than HIV-1 and
HIV-2 2R ssDNAs. Moreover, when mutations were in-
troduced in the HIV-1 TAR-1 sequence to remove most of
the mismatches and stabilize the hairpin, self-priming
was enhanced (Driscoll and Hughes, 2000). With all
these 2R ssDNAs (Driscoll and Hughes, 2000; this pa-
per), the efficiency of self-priming increased with the
relative stability of the structures that could induce self-
priming. The most important factor affecting the ability of
a given DNA to self-prime is the stability of the structures
that can self-prime relative to the stability of the struc-
tures that cannot self-prime. Thus, the distribution of the
2sssDNA molecules among the different possible con-
formations is governed by the difference in free energy
between the structures. The structure with the lowest
free energy will be present at the highest concentration.
If one of the most stable structures has the 39 enddouble-stranded, then self-priming will occur. The effi-
ciency of the self-priming reaction will depend on the
difference of free energy between these structures that
can self-prime and those that cannot.
When a DNA oligonucleotide complementary to the 39
end of 2R ssDNA is used, annealing will occur only if the
energy decrease due to the formation of the oli-
gomer/2R ssDNA duplex is higher than the energy in-
crease due to disruption of the secondary structure ele-
ment at the 39 end of 2R ssDNA. Consequently, the
base-pairing at the 39 end structural element, the number
and the position of bases not involved in canonical
Watson–Crick basepairs, and the percentage of G/C
basepairs that can be formed will affect the size of the
oligomer needed to disrupt the structural element. In the
case of HIV-1 2R ssDNA, we calculated the T m of DNA
oligonucleotides complementary to the 39 end. The
shortest DNA oligonucleotide having a T m higher than
the T m of TAR-1 is 17 nt long (data not shown). In the case
of the enhanced TAR-1 hairpin, calculations of the rela-
tive energies suggested that the hairpin cannot be dis-
rupted if an oligonucleotide shorter than 23 bases is
used (data not shown). In practice, self-priming still oc-
curred in the presence of a 21-mer DNA oligonucleotide
even in the presence of NC (Driscoll and Hughes, 2000).
HTLV-1 2R ssDNA is longer and has more extensive
secondary structures than HIV-1 2R ssDNA but the
structure responsible for the self-priming is not the over-
all R structure but a relatively small stem loop at the 39
end of 2R ssDNA containing only 5 basepairs. In this
case, self-priming can be prevented by annealing a DNA
oligonucleotide that can disrupt the small and imperfect
stem loop involving the 39 end 25 nucleotides. In the
presence of HIV-1 NC, a 10-nt-long DNA significantly
reduced the amount of self-priming and a 14-nt-long DNA
oligonucleotide completely blocked the formation of the
self-primed product. In the case of HIV-2 2R ssDNA, the
possible secondary structure elements have relatively
poor basepairing at the 39 end of the 2R ssDNA (this
structure contains both mispairs and 1-base bulges) and
a 14-nt-long DNA oligonucleotide is able to prevent self-
priming in the presence of NC.
In the most stable structure, each of the individual
structural elements contributes to the decrease in the
free energy of the R structure. Consequently, the second-
ary structure with the overall lowest energy may have a
structural element at the 39 end that is relatively unsta-
ble. Thus, in the case of HTLV-1 2R ssDNA, for example,
self-priming is favored because the most stable structure
has a double-stranded 39 end. However, the 39 end
secondary structure elements are not particularly stable
and, consequently, can be disrupted relatively easily.
Even in the absence of HIV-1 NC, self-priming of 2R
ssDNA can be prevented by annealing a DNA oligonu-
cleotide. If NC is absent, the oligonucleotide must either
be similar in size (HTLV-1) or larger (HIV-1, HIV-2) than in
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2872sssDNA SELF-PRIMINGthe presence of NC. These results clearly show that
HIV-1 NC is not always required to block self-priming
with a DNA oligonucleotide as previously proposed
(Driscoll and Hughes, 2000) but that NC can reduce the
size of the oligonucleotide necessary to block self-
priming.
With HIV-1 2R ssDNA, the size of the oligonucleotide
required to block the self-priming in the presence of NC
was similar to the size predicted by thermodynamic cal-
culations. The fact that the experimental results are in
agreement with the thermodynamic calculations sug-
gests that the presence of a twofold excess of NC does
not significantly affect the thermodynamics of the sys-
tem. However with either HTLV-1 or HIV-2 2R ssDNA,
NC can, by itself, reduce self-priming by more than 50%.
When similar experiments were performed with HIV-1
2R ssDNA, the effect was more modest (a reduction of
approximately 10% in the amount of the self-primed prod-
uct). There are two simple explanations. First, NC could
slow the rate of the polymerization. If the polymerization
rate was affected, we would expect to see a similar level
of inhibition with all three 2R ssDNAs. This explanation
is not consistent with the fact that there is a much larger
effect on self-priming of HIV-2 and HTLV-1 2R ssDNAs
than HIV-1 2R ssDNA (Driscoll and Hughes, 2000; this
paper). Second, NC could affect directly the ability of a
2R ssDNA to self-prime. It has been suggested that
nucleic acid chaperone activity of HIV-1 NC destabilizes
secondary structures in RNA and ssDNA and, conse-
quently, facilitates the progression of RT through the
genome (Khan and Giedroc, 1992; Tsuchihaschi and
Brown, 1994). We found that it was easier to prevent the
self-priming of HIV-2 and HTLV-1 2R ssDNAs than HIV-1
2R ssDNA by annealing a DNA oligonucleotide in the
absence of NC. This suggests that it is easier to desta-
bilize the structural element formed from the 39 end of
the HIV-2 and HTLV-1 2R ssDNAs than HIV-1 2R ssDNA
(the change in free energy due to the formation of struc-
tural element at the 39 end is smaller for HIV-2 and
HTLV-1 2R ssDNAs than for HIV-1 2R ssDNA). If the
change of free energy produced by NC binding is similar
for the three 2R ssDNAs, then we could expect a greater
effect on the self-priming of HIV-2 and HTLV-1 2R
ssDNAs than for HIV-1 2R ssDNA. If the difference of
free energy between conformations that can self-prime
and those that cannot self-prime is large (for example, in
the modified form of HIV-1 2R ssDNA), the small
changes that NC may introduce into the thermodynamics
of the system might be too modest to affect the distribu-
tion between conformations and, consequently, to affect
self-priming. But, when this difference of energy between
conformations is small (HIV-2 and HTLV-1 2R ssDNAs,
for example), the distribution between conformations
could be quite sensitive to NC. A simple interpretation of
our results (decrease of self-priming in presence of NC)
would be that NC destabilizes double-stranded DNA asproposed previously by others (Khan and Giedroc, 1992;
Tsuchihaschi and Brown, 1994) and changes the distri-
bution of the molecules in the various possible confor-
mations.
Even though these three retroviruses have R regions
that differ significantly in size and overall secondary
structure, in every case the self-priming of 2R ssDNA
can be prevented by a 14- to 17-nt-long DNA oligonucle-
otide and HIV-1 NC (Driscoll and Hughes, 2000; this
paper). However, in some cases like HIV-1 and HIV-2 2R
ssDNAs, a much longer DNA oligonucleotide is required
to block self-priming in absence of NC. Driscoll et al.
(2001) showed that HIV-1 RT leaves a 14-base-long RNA
oligonucleotide annealed to the 39 end of HIV-1
2sssDNA. RNA fragments of similar size (14 to 18 nt)
were formed with avian myeloblastosis virus, Moloney
murine leukemia virus (Fu and Taylor, 1992), and Ty1
(Wilhelm et al., 2000) RTs. The size of the RNA oligonu-
leotide left at the 39 end of 2sssDNA is similar in size
o the DNA oligonucleotide needed to prevent the self-
riming of 2sssDNA in presence of NC. Thus, even
hen the R region contains relatively large secondary
tructure elements, the RNA oligonucleotide remaining
fter RNase H degradation of the RNA template is suffi-
ient to prevent the self-priming of 2sssDNA in our
experiments. Although there are secondary structures in
R regions that are needed for interaction with trans-
activating proteins [Tax for HIV-1 and HIV-2, Rex with
HTLV-1 (Coffin et al., 1997)], the 39 ends of the
2sssDNAs that contain the complement of these RNA
structures are sufficiently unstable that the residual RNA
oligonucleotide left after degradation of the RNA tem-
plate by RT is long enough to prevent self-priming of the
2sssDNAs. Thus, sequences found at the 59 end of
some retroviruses have been optimized to form RNA
secondary structures necessary for interactions with
other retroviral proteins. However, successful reverse
transcription requires that the structures at the 39 end of
he 2sssDNA be sufficiently unstable that self-priming
an be prevented by the 14- to 18-nucleotide-long RNA
ragment derived from the 59 end of the genome by
Nase H digestion.
We also found that if the 39 end of 2R ssDNA is
nnealed to a complementary DNA oligonucleotide, it is
good substrate for strand transfer to other ssDNA
olecules in solution even when such ssDNA acceptors
ere present in low concentration. When the 2sssDNA
ynthesis is complete, the RNase H activity degrades the
NA template, leaving a RNA segment annealed to the 39
nd of 2sssDNA. At the step just before the first strand
ransfer, the 39 end of 2sssDNA is hybridized to a short
NA fragment. This is a similar structure to the DNA/
NA hybrid that serves as a strand transfer donor in our
n vitro assay. If such strand transfer occurred in vivo, it
would interfere with the normal synthesis of viral DNA.
More studies are necessary to understand this nonspe-
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288 GOLINELLI AND HUGHEScific strand transfer reaction and how this type of reac-
tion is prevented in vivo.
MATERIALS AND METHODS
Wild-type HIV-1 RT (p66/p51) and wild-type HIV-2 RT
(p68/p68) were expressed in Escherichia coli and puri-
fied as described previously (Boyer et al., 1994; Hizi et al.,
1991). HIV-1 nucleocapsid protein (p7 Zn21 NC) was gen-
erously provided by Drs. Robert Gorelick, Louis Hender-
son, and Larry Arthur (SAIC Frederick). A 30 mM NC
solution was prepared by dissolving lyophilized NC in
13 RT binding buffer [50 mM Tris–HCl, pH 8.3, 80 mM
KCl, 1 mM dithiothreitol (DTT), 0.1 mg/ml bovine serum
albumin (BSA)] and 20% glycerol. NC was stored in 4-ml
aliquots in 150-ml tubes at 280°C. Fresh aliquots were
hawed immediately prior to use.
Oligonucleotides, including the 100-mer used to rep-
esent the 59 end of HIV-1 2sssDNA, were purchased
rom Gibco BRL. The 59 end-labeling was performed
sing [g-32P]ATP (Amersham Pharmacia Biotech) and T4
olynucleotide kinase (New England Biolabs). Products
ere purified on a G-25 spin column (Millipore). Gel
maging and quantitation were performed using a Mo-
ecular Dynamics Storm 860 PhosphorImager using Im-
geQuant software version 5.0.
NA and RNA secondary structure predictions
DNA and RNA secondary structure predictions were
ade using mfold version 3.0 software available on the
uker and Turner web site (http://mfold2.wustl.edu/
mfold). The algorithms are based on published meth-
ds for RNA (Mathews et al., 1999; Zuker et al., 1999) and
for DNA (SantaLucia, 1998). For the RNA calculations, the
conditions were fixed by the program at 1 M NaCl, 0 mM
MgCl2, and 37°C. For the DNA, calculations were per-
ormed at 37°C with oligomer corrections and 80 mM
aCl, 6 mM MgCl2, which is equivalent to the salt com-
position of the buffer used in most of the experiments.
R RNA synthesis
For HIV-2 and HTLV-1, R RNAs correspond exactly to
the R region of the genomic RNAs (173 and 228 nt,
respectively). For HIV-1, R RNA corresponds to the 4
bases at the 59 end of U5 and 96 bases of the R region.
R RNA from HIV-1 was prepared as described previously
(Driscoll and Hughes, 2000). DNAs from HIV-2 and
HTLV-1 were amplified in a fashion that they would
contain a T7 promoter at the 59 end of the R region. PCRs
were done using the Expand High Fidelity PCR system
kit (Roche Molecular Biochemicals). Plasmid templates
for the PCR reactions were pROD1.12 containing the
HIV-2 provirus (a generous gift from Drs. M. Emerman
and L. Montagnier) and pUC-LTR containing the SmaI-
to-RsaI fragment (positions 31 to 681) of HTLV-1 provirus(a generous gift from Dr. D. Derse). One oligonucleo-
tide used in the amplification contained a modified T7
promoter and the 59 end of the R region (59-TTACGCCAA-
GCTACGTAATACGACTCACTATAGGTCGCTCTGCGGAG-
AGGCTGGCAGATTG for HIV-2 and 59-TTACGCCAAGCT-
ACGTAATACGACTCACTATAGGCTCGCATCTCTCCTTC-
ACGCGCCCG for HTLV-1). The second oligonucleotide
was complementary to the 39 end of R (59-TGCTTCTA-
ACTGGCAGC for HIV-2 and 59-TAGAGTTGAGCAAG-
CAGGGTC for HTLV-1). The PCR products were gel pu-
rified and used as templates for RNA synthesis with the
MEGAshortscript kit (Ambion) according to the manufac-
turer’s instructions. After RNA synthesis, the double-
stranded DNA template was removed by DNase I diges-
tion and the RNA purified by electrophoresis on a 5%
denaturing polyacrylamide gel. The RNA band was visu-
alized under UV and excised. RNA was eluted overnight
in the presence of proteinase K. After phenol extraction
and precipitation, RNA was quantitated by absorbance at
260 nm.
Internally labeled 2R ssDNA synthesis
R RNA was used as template for 2R ssDNA synthesis.
The RNA template was annealed to the oligonucleotide
complementary to the 39 end of the R region in Super-
Script II first strand buffer. The complementary DNA
strand (2R ssDNA) was synthesized using SuperScript II
RNase H2 reverse transcriptase enzyme (Gibco BRL) in
the presence of cold dNTPs (160 nmol each except
dGTP, 3.2 nmol) and [a-32P]dGTP (Amersham Pharmacia)
or 3 h at 42°C according to the manufacturer’s instruc-
ions. Then the RNA template was removed by RNase A
igestion; the DNA was gel purified, eluted, and quanti-
ated as described previously for the RNA.
everse transcription assays
RNA templates were mixed with a fivefold molar ex-
ess of the 32P-59-end-labeled oligonucleotide comple-
entary to the 39 end of the template in 13 RT binding
uffer (50 mM Tris–HCl, pH 8.3, 80 mM KCl, 1 mM DTT,
.1 mg/mL BSA). The mixture was incubated at 65°C for
min and allowed to cool to room temperature. Then
03 RT start solution containing dNTPs (80 mM final
each) and MgCl2 (6 mM final) was added. For reactions
containing NC, the protein was added and the reaction
mixture was incubated for 5 min at 37°C. Reactions were
started by addition of HIV-1 RT and stopped after 1 h by
addition of an equal volume of 90% formamide stop
solution containing 1% SDS, 4 mg/ml of DNA plasmid,
bromophenol blue, and xylene cyanole. Reactions were
heated at 95°C for 5 min and fractionated by electro-
phoresis on a 4 or 5% denaturing polyacrylamide gel
containing 0.5% SDS. The gel was dried under vacuum,
exposed to a PhosphorImager screen (Molecular Dy-
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2892sssDNA SELF-PRIMINGnamics), and quantitated using ImageQuant software
version 5.0.
2R ssDNA self-priming assays
HIV-1 block, HIV-2 block, and HTLV block oligonucle-
otides are DNA oligonucleotides complementary to the
39 end of 2R ssDNA of, respectively, HIV-1, HIV-2, and
HTLV-1 2R ssDNAs (Fig. 3). 32P internally labeled 2R
sDNA was mixed with 70-fold excess of the indicated
NA blocking oligonucleotide (when needed) in 13 RT
inding buffer. The mixture was heated at 65°C for 3 min
nd allowed to cool to room temperature. RT start solu-
ion and NC protein (when needed) were added and the
ixture was incubated for 5 min at 37°C. Reactions were
tarted by addition of RT, performed in the indicated
uffer at 37°C, and stopped after 1 h by addition of an
qual volume of formamide stop solution. Product anal-
sis was performed as described previously.
R ssDNA self-priming assays using G-50 spin
olumn
DNA blocking oligonucleotides were annealed to the
R ssDNA template as described previously and unan-
ealed oligonucleotides were removed by fractionating
he mixture on a 1-ml G-50-spin column (Millipore) equil-
brated with 13 RT binding buffer. Then DNA blocking
ligonucleotide (when needed), RT start solution, and RT
nzyme were added. The reaction was performed in
.73 RT binding buffer at 37°C and stopped by addition
f an equal volume of formamide stop solution after 1 h.
roduct analysis was performed as described previously.
equencing of reaction products
Sequencing of reaction products was performed in 13
T binding buffer in the presence of 133 mM each dNTP
and 1.6 mM dideoxynucleotide for 1 h at 37°C. Then the
NA was annealed to HIV-2 block 35 oligonucleotide
HIV-2 2R ssDNA, Fig. 3) or HTLV block 30 oligonucleo-
ide (HTLV-1 2R ssDNA, Fig. 3) added in 200-fold excess
nd digested with BanII (HIV-2) or with CfoI (HTLV-1).
igestion products were analyzed on a 12% denaturing
crylamide gel.
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